SCHEMBL21591731

SCHEMBL21591731

O=C(O)N1Cc2cc(Br)cnc2C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 2/20 0.59
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSP90AA1 P07900 2/20 0.36
HPGDS O60760 2/20 0.34
ALDH1A1 P00352 3/20 0.33
POLB P06746 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
GAA P10253 2/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GRM5 P41594 2/20 0.32
AKR1C3 P42330 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
CCR2 P41597 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723952 0.86 ABHD6 (0.49) ABHD6HPGDHTTSMN1; SMN2HSP90AA1
SCHEMBL28511316 0.86 ABHD6 (0.49) ABHD6HPGDHTTSMN1; SMN2HSP90AA1
SCHEMBL21802762 0.85 ABHD6 (0.58) ABHD6HPGDHTTSMN1; SMN2HSP90AA1
SCHEMBL29377808 0.78 ABHD6 (0.64) ABHD6MAPT
SCHEMBL15779392 0.78 ABHD6 (0.64) ABHD6MAPT
SCHEMBL31013839 0.78 ABHD6 (0.39) ABHD6HPGDSPOLBTDP1RECQL
SCHEMBL23496046 0.76 ABHD6 (0.38) ABHD6HPGDSPOLBTDP1RECQL
SCHEMBL29972597 0.76 RYR2 (0.44) ABHD6KDM4EKCNH2
SCHEMBL27245877 0.76 RYR2 (0.44) ABHD6KDM4EKCNH2
SCHEMBL14995412 0.76 ABHD6 (0.38) ABHD6HPGDHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 CN disclosed
EP-3807270-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
WO-2019238616-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed